Reaction Details |
| Report a problem with these data |
Target | Kappa-type opioid receptor |
---|
Ligand | BDBM50304074 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_601579 (CHEMBL1047759) |
---|
IC50 | 1.03±n/a nM |
---|
Citation | Deb, I; Paira, P; Hazra, A; Banerjee, S; Dutta, PK; Mondal, NB; Das, S Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence. Bioorg Med Chem17:5782-90 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Kappa-type opioid receptor |
---|
Name: | Kappa-type opioid receptor |
Synonyms: | K-OR-1 | KOR-1 | Kappa-opioid receptor (KOR) | Kappa-type opioid receptor (KOPR) | Kappa-type opioid receptor (KOR) | Kappa-type opioid receptor (Kappa) | OPIATE Kappa | OPRK | OPRK1 | OPRK_HUMAN | kappa opioid receptor (KOR) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 42648.76 |
Organism: | Homo sapiens (Human) |
Description: | P41145 |
Residue: | 380 |
Sequence: | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPV
IITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYL
MNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINI
CIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVL
IIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALG
STSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRV
RNTVQDPAYLRDIDGMNKPV
|
|
|
BDBM50304074 |
---|
n/a |
---|
Name | BDBM50304074 |
Synonyms: | 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide | CHEMBL594511 |
Type | Small organic molecule |
Emp. Form. | C18H17N3O |
Mol. Mass. | 291.3471 |
SMILES | Cc1cc(NCC(=O)Nc2ccccc2)c2ccccc2n1 |
Structure |
|